Galanin/GALP Receptors and CNS Homeostatic Processes

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 327-334

Bentham Science Publishers

Access to resources Recommend Favorite

Galanin receptors and their therapeutic potential

By Wang S.   Hwa J.   Varty G.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 4, 2000-12 ,pp. : 415-440

Informa Healthcare

Access to resources Recommend Favorite

The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 183-192

Bentham Science Publishers

Access to resources Recommend Favorite

The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15)

By Narvaez J.A.   Daz-Cabiale Z.   Hedlund P.B.   Aguirre J.A.   Covenas R.   Gonzalez-Baron S.   Fuxe K.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite

Galantide distinguishes putative subtypes of galanin receptors in mudpuppy parasympathetic neurons

By Mulvaney J.M.   Merriam L.A.   Parsons R.L.  

European Journal of Pharmacology, Vol. 287, Iss. 1, 1995-12 ,pp. : 97-100

Elsevier

Access to resources Recommend Favorite